INDENTURE Dated as of ______________ Debt SecuritiesIndenture • March 18th, 2016 • Flex Pharma, Inc. • Pharmaceutical preparations • New York
WHEREAS, for its lawful corporate purposes, the Company has duly authorized the execution and delivery of this Indenture to provide for the issuance of debt securities (hereinafter referred to as the “Securities”), in an unlimited aggregate principal amount to be issued from time to time in one or more series as in this Indenture provided, as registered Securities without coupons, to be authenticated by the certificate of the Trustee;
WARRANT AGREEMENT DATED AS OF _____________Common Stock Warrant Agreement • March 18th, 2016 • Flex Pharma, Inc. • Pharmaceutical preparations • New York
between FLEX PHARMA, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
WARRANT AGREEMENT DATED AS OF ______________Warrant Agreement • March 18th, 2016 • Flex Pharma, Inc. • Pharmaceutical preparations • New York
WHEREAS, the Company has entered into an indenture dated as of (the “Indenture”), with , as trustee (such trustee, and any successors to such trustee, herein called the “Trustee”), providing for the issuance from time to time of its debt securities, to be issued in one or more series as provided in the Indenture (the “Debt Securities”);
WARRANT AGREEMENT DATED AS OF ___________Preferred Stock Warrant Agreement • March 18th, 2016 • Flex Pharma, Inc. • Pharmaceutical preparations • New York
between FLEX PHARMA, INC., a Delaware corporation (the “Company”) and , a [corporation] [national banking association] organized and existing under the laws of and having a corporate trust office in , as warrant agent (the “Warrant Agent”).
